CVS Caremark Corporation (NYSE:CVS) announced that Larry Merlo, the company’s president and chief executive officer, will be making a presentation to investors at the UBS Global Healthcare Conference on May 20, 2014. Mr. Merlo is scheduled to present at approximately 8:00 a.m. (EDT). CVS Caremark Corporation (NYSE:CVS) net profit margin is 4.40% and weekly performance is 2.45%. On last trading day company shares ended up $76.82. Analysts mean target price for the company is $80.08. CVS Caremark Corporation (NYSE:CVS) distance from 50-day simple moving average (SMA50) is 4.29%.
Nokia Corporation (ADR) (NYSE:NOK)has just launched the Lumia 630 at a starting price of Rs 10,500 and it will be competing mainly with the Moto G which has been creating waves for a while at a starting price of Rs 12,499. Nokia Corporation (ADR) (NYSE:NOK) shares advanced 2.76% in last trading session and ended the day on $7.44. NOK Gross Margin is 42.10% and its return on assets is -4.50%. Nokia Corporation (ADR) (NYSE:NOK) quarterly performance is 0.81%.
BioScript Inc. (NASDAQ:BIOS) first quarter results reflect the company’s effort in achieving a viable strategic platform in the home infusion industry, as well as generating strong cash collections. The quarter saw the company reach double digit organic growth in infusion Services with further growth expected through the expanded operating footprint. BioScript Inc. (NASDAQ:BIOS)’s cost of product revenues increased by 43.9% to $215.9 million with the cost of service revenues declining by23.7% to $23.9 million. BioScript infusion franchise is in line to grow through organic and inorganic means. Recent acquisitions and sell outs are expected to be accretive of the company’s top line. With Infusion services expected to deliver double digit organic revenue growth, BioScript Inc. (NASDAQ:BIOS) expects its 2014 revenue to be in the range of between $940 million and $980 million. BioScrip Inc (NASDAQ:BIOS) shares moved down -1.96% in last trading session and was closed at $6.99, while trading in range of $6.97 – $7.32. BioScrip Inc (NASDAQ:BIOS) year to date (YTD) performance is -5.54%.
PharMerica Corporation (NYSE:PMC)a national provider of institutional, specialty home infusion, and oncology pharmacy services, announced that Gregory Weishar, Chief Executive Officer, will make a presentation regarding the Company at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas, Nevada on Wednesday, May 14, 2014, at 8:00 a.m. Pacific Daylight Time. The Company also announced that a live broadcast of its conference presentation, as well as any written materials accompanying the presentation, will be available on the “For Investors” tab of the Company’s website, www.pharmerica.com, under “Webcasts and Presentations.” In addition, the webcast, transcript and written materials will be archived on the Company’s website following the event. PharMerica Corporation (NYSE:PMC) ended the last trading day at $28.91. Company weekly volatility is calculated as 3.95% and price to cash ratio as 35.83. PharMerica Corporation (NYSE:PMC) showed a positive weekly performance of 2.41%.
Aetna Inc (NYSE:AET) announced that Shawn M. Guertin, executive vice president and CFO, is scheduled to make a presentation at the Bank of America Merrill Lynch Health Care Conference on May 14, 2014, in Las Vegas. Aetna’s presentation is scheduled to begin at 2:20 p.m. ET (11:20 a.m. PT). Aetna Inc (NYSE:AET) net profit margin is 4.00% and weekly performance is 4.81%. On last trading day company shares ended up $75.77. Analysts mean target price for the company is $82.94. Aetna Inc (NYSE:AET) distance from 50-day simple moving average (SMA50) is 4.38%.